Growth Metrics

InspireMD (NSPR) Free Cash Flow (2016 - 2025)

InspireMD filings provide 16 years of Free Cash Flow readings, the most recent being -$9.7 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 37.98% to -$9.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$36.8 million, a 57.99% decrease, with the full-year FY2025 number at -$36.8 million, down 57.99% from a year prior.
  • Free Cash Flow hit -$9.7 million in Q4 2025 for InspireMD, down from -$9.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$2.6 million in Q2 2021 to a low of -$9.7 million in Q4 2025.
  • Median Free Cash Flow over the past 5 years was -$4.6 million (2023), compared with a mean of -$5.3 million.
  • Biggest five-year swings in Free Cash Flow: rose 22.35% in 2023 and later tumbled 84.49% in 2025.
  • InspireMD's Free Cash Flow stood at -$3.0 million in 2021, then decreased by 9.38% to -$3.3 million in 2022, then tumbled by 33.5% to -$4.4 million in 2023, then crashed by 60.77% to -$7.1 million in 2024, then crashed by 37.98% to -$9.7 million in 2025.
  • The last three reported values for Free Cash Flow were -$9.7 million (Q4 2025), -$9.0 million (Q3 2025), and -$8.9 million (Q2 2025) per Business Quant data.